Does CARFILZOMIB Cause Progressive multifocal leukoencephalopathy? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Progressive multifocal leukoencephalopathy have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.3% of all adverse event reports for CARFILZOMIB.
69
Reports of Progressive multifocal leukoencephalopathy with CARFILZOMIB
0.3%
of all CARFILZOMIB reports
34
Deaths
25
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From CARFILZOMIB?
Of the 69 reports, 34 (49.3%) resulted in death, 25 (36.2%) required hospitalization, and 17 (24.6%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which CARFILZOMIB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL